Is Measurement of Systemic IgG Antibodies the Wrong Way to Assess COVID-19 Vaccine Effectiveness for Breakthrough Infections?

被引：0
|
作者：
Levinson, Stanley S. [1 ]
机构：
[1] Univ Louisville, Dept Med, Div Endocrinol Metab & Diabet, Louisville, KY 40202 USA
来源：
JOURNAL OF APPLIED LABORATORY MEDICINE | 2022年 / 7卷 / 05期
关键词：
MUCOSAL IMMUNITY; POLIOVIRUS;
D O I：
10.1093/jalm/jfac049
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1242 / 1244
页数：3
相关论文
共 50 条
  • [31] Comparison Of serum Anti-Spike (S) IgG Covid-19 Antibody between Breakthrough Infection And recent COVID-19 Infections in unvaccinated
    De, Sajal
    Sahu, Dibakar
    Mahilang, Diksha
    Bhargava, Anudita
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [32] The impact of HLA-DQB1*06 alleles on COVID-19 vaccine effectiveness: An analysis of SARS-CoV-2 antibodies and breakthrough infections based on UK Biobank
    Xie, Junqing
    Mothe, Beatriz
    Prieto-Alhambra, Daniel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 81 - 81
  • [33] COVID-19 Vaccine Development and the Way Forward
    Arora, Narendra Kumar
    Das, Manoja Kumar
    INDIAN JOURNAL OF PUBLIC HEALTH, 2020, 64 : 108 - 111
  • [34] COVID-19 vaccine hesitancy in systemic sclerosis
    Ciaffi, J.
    Giuggioli, D.
    Mari, A.
    D'Onghia, M.
    Spinella, A.
    Brusi, V.
    Mancarella, L.
    Lisi, L.
    Cordella, J. Faranda
    Freeman, D.
    Landini, M. P.
    Ferri, C.
    Meliconi, R.
    Ursini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : S165 - S166
  • [35] EXAMINING THE RATE OF COVID-19 BREAKTHROUGH INFECTIONS IN INDIVIDUALS WHO RECEIVED MRNA VACCINE IN THE UNITED STATES
    Madge, V
    Bhardwaj, N.
    Mazumder, D.
    VALUE IN HEALTH, 2022, 25 (01) : S271 - S271
  • [36] WHAT ARE RISK FACTORS FOR COVID-19 VACCINE BREAKTHROUGH INFECTIONS IN PATIENTS WITH PREVIOUS HISTORY OF BARIATRIC SURGERY?
    Sarno, Gerardo
    Calabrese, Pietro
    Schiavo, Luigi
    Izzo, Francesco
    Pilone, Vincenzo
    EXCLI JOURNAL, 2022, 21 : 786 - 790
  • [37] Feasibility of Measuring Physiological Responses to Breakthrough Infections and COVID-19 Vaccine Using a Wearable Ring Sensor
    Pho G.N.
    Thigpen N.
    Patel S.
    Tily H.
    Digital Biomarkers, 2023, 7 (01) : 1 - 6
  • [38] COVID-19 Breakthrough Infections Among Patients with Cancer Receiving Sinopharm BBIBP-CorV Vaccine
    Manteghinejad, Amirreza
    Arabzadeh, Saeedeh
    Rezaian, Zahra
    Sharifi, Mehran
    Javanmard, Shaghayegh Haghjooy
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2022, 15 (10)
  • [39] COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN SJOGREN'S SYNDROME: RESULTS FROM THE COVAD STUDY
    Alunno, A.
    Carubbi, F.
    Day, J.
    Knitza, J.
    Shinjo, S. Katsuyuki
    Saha, S.
    Milchert, M.
    Distler, O.
    Makol, A.
    Chatterjee, T.
    Agarwal, V.
    Aggarwal, R.
    Gupta, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 372 - 373
  • [40] Persistence of IgG COVID-19 antibodies: A longitudinal analysis
    Carvalho, Alvaro
    Henriques, Ana Rita
    Queiros, Paula
    Rodrigues, Joana
    Mendonca, Nuno
    Rodrigues, Ana Maria
    Canhao, Helena
    de Sousa, Germano
    Antunes, Francisco
    Guimaraes, Miguel
    FRONTIERS IN PUBLIC HEALTH, 2023, 10
12345